Sciformix CEO Recognized as Most Talented Leader in Outsourcing
News Feb 23, 2016
Soman has been recognized for his exceptional track record and exemplary achievements and notable contributions to the life science outsourcing industry during the Asia Outsourcing Leadership Summit on February 19, 2016 at Taj Lands End, Mumbai.
According to the Asia Outsourcing Leadership Summit, Business Process Outsourcing (BPO) is entering a new age as companies strive for improved outcomes, lower costs and higher standards in a critically competitive economic environment. As a result, outsourcing has become an essential and strategic component of many leading life science organization’s growth path as they seek to focus on their core competencies of developing safe and effective medical products. Significant global, regulatory, technology and other trends have impacted the way companies do business and the level of understanding and knowledge professionals require in order to be successful. The outsourcing industry demands exemplary outsourcing leaders, with strong skill sets in areas such as business case development and deal structuring.
Manish Soman was selected for his track record of building successful outsourcing companies, including his recent role as President and CEO at Sciformix Corporation, a best in class life science scientific services organization. His leadership has helped the company to create long-term partnerships with companies who develop innovative medical products and improve the quality of healthcare globally.
On the announcement of the win, Manish commented, “I am deeply honored to be chosen among the ‘Most Talented Leaders in Outsourcing Industry’ and at the same time humbled to be in the company of such innovative and accomplished leaders.”
He added, “Outsourcing is increasingly becoming part of a company's core business strategy. Whether an organization is a current user of global sourcing or is considering such a move, this summit is a great platform to get a perspective from around the globe. The highlight of this event is that it brings together the greatest minds from the industry to reflect on the critical juncture at which the industry stands and discuss the need for innovative solutions that ensure sustained growth and success in the industry.”
The Asia Outsourcing Awards recognize leaders who demonstrate best practices and behaviors in the outsourcing industry that help their clients create and sustain a competitive advantage, realize business transformation, achieve sustained value for the both the buyer and service provider. These awards form an industry benchmark in terms of best practices and business excellence. The recipients are decided by a jury of industry professionals from across the globe that meticulously monitor and research individuals who consistently do extraordinary work and track the record of their achievements over a period of time. The “Most Talented Leaders in the Outsourcing Industry” recognizes these eminent professionals for their superlative achievements in the field of outsourcing.
Sciformix, headquartered in the USA, with operations in India and the Philippines, partners with life science clients through the entire drug development cycle, to provide a full range of services from study design to post-marketing surveillance and commercialization support. Areas of specialization include Safety and Risk Management, Clinical Research & Post Approval Support Services, Medical Affairs, Scientific Writing and Regulatory Affairs.
PhoreMost and Plexxikon Collaborate to Identify Novel Drug TargetsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has signed a collaborative agreement with Plexxikon Inc., the small molecule structure-guided R&D centre of Daiichi Sankyo.READ MORE
Lonza Opens World’s Largest Dedicated Cell-and-Gene-Therapy Manufacturing Facility in TexasNews
First-of-its-kind, state-of-the-art manufacturing facility with capacity to produce treatment for thousands of patients suffering from rare genetic disorders or life-threatening diseases.READ MORE
IONTAS and IGEM Therapeutics Collaborate to Identify Novel IgE AntibodiesNews
The project will add to IGEM’s pipeline of drugs and expand upon IGEM-F, an IgE targeting ovarian and other cancers, currently in a Phase 1/2a study.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Biomaterials and Tissue Engineering
Jun 20 - Jun 21, 2018